Nature research paper: De novo design of luciferases using deep learning
). Research reported in this publication was partially supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award number K99EB031913. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, USASchool of Chemistry, Xi’an Key Laboratory of Sustainable Energy Materials Chemistry, MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, Xi’an Jiaotong University, Xi’an, China
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
High-throughput microbial culturomics using automation and machine learning - Nature BiotechnologyA machine learning isolation and genotyping platform enable high-throughput bacterial culture generation.
Read more »
When to update COVID-19 vaccine composition - Nature MedicineVaccines against different SARS-CoV-2 variants have been approved, but continued surveillance is needed to determine when the antigen composition of vaccines should be updated, together with clinical studies to assess vaccine efficacy.
Read more »
Epidural stimulation of the cervical spinal cord for post-stroke upper-limb paresis - Nature MedicineElectrical stimulation of cervical spinal circuits facilitates arm & hand movements in two participants with moderate & severe chronic post-stroke hemiparesis. MCapogrosso PittNeurosurg
Read more »
Putting CRISPR into African hands to future-proof crops - Nature BiotechnologyScientists from seven countries embark on training to use gene editing tools to improve the continent’s neglected crops.
Read more »
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression - Nature BiotechnologyHypoimmune engineering of cell therapies is extended to protection from host antibodies.
Read more »